Closing Strong: Cullinan Therapeutics Inc (CGEM) Ends at 17.43, Down -0.46 from Last Close

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

After finishing at $17.51 in the prior trading day, Cullinan Therapeutics Inc (NASDAQ: CGEM) closed at $17.43, down -0.46%. In other words, the price has decreased by -$0.46 from its previous closing price. On the day, 2.32 million shares were traded. CGEM stock price reached its highest trading level at $18.03 during the session, while it also had its lowest trading level at $17.18.


Our goal is to gain a better understanding of CGEM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 20.33 and its Current Ratio is at 20.33. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on May 01, 2024, initiated with a Buy rating and assigned the stock a target price of $40.

On February 15, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $30.Wedbush initiated its Outperform rating on February 15, 2024, with a $30 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 07 ’24 when Michaelson Jennifer sold 5,606 shares for $30.06 per share. The transaction valued at 168,516 led to the insider holds 129,582 shares of the business.

Michaelson Jennifer sold 58,000 shares of CGEM for $1,628,159 on May 06 ’24. The Chief Scientific Officer now owns 129,582 shares after completing the transaction at $28.07 per share. On Feb 01 ’24, another insider, Savill Corrine, who serves as the Chief Business Officer of the company, sold 40,000 shares for $16.18 each. As a result, the insider received 647,200 and left with 165,990 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGEM now has a Market Capitalization of 1004564096 and an Enterprise Value of 574722688.

Stock Price History:

Over the past 52 weeks, CGEM has reached a high of $30.19, while it has fallen to a 52-week low of $7.64. The 50-Day Moving Average of the stock is -22.16%, while the 200-Day Moving Average is calculated to be 18.93%.

Shares Statistics:

The stock has traded on average 865.48K shares per day over the past 3-months and 1254520 shares per day over the last 10 days, according to various share statistics. A total of 57.63M shares are outstanding, with a floating share count of 43.95M. Insiders hold about 23.74% of the company’s shares, while institutions hold 45.27% stake in the company. Shares short for CGEM as of 1715731200 were 3742326 with a Short Ratio of 5.02, compared to 1713139200 on 1678317. Therefore, it implies a Short% of Shares Outstanding of 3742326 and a Short% of Float of 7.539999999999999.

Most Popular